GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » E10

JW Pharmaceutical (XKRX:001060) E10 : ₩115.61 (As of Mar. 2024)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

JW Pharmaceutical's adjusted earnings per share data for the three months ended in Mar. 2024 was ₩816.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩115.61 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of JW Pharmaceutical was 33.30% per year. The lowest was -70.80% per year. And the median was -49.80% per year.

As of today (2024-06-05), JW Pharmaceutical's current stock price is ₩29600.00. JW Pharmaceutical's E10 for the quarter that ended in Mar. 2024 was ₩115.61. JW Pharmaceutical's Shiller PE Ratio of today is 256.03.

During the past 13 years, the highest Shiller PE Ratio of JW Pharmaceutical was 3486.85. The lowest was 248.25. And the median was 1671.12.


JW Pharmaceutical E10 Historical Data

The historical data trend for JW Pharmaceutical's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical E10 Chart

JW Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -293.97 -399.07 -350.74 -87.39 41.23

JW Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30.01 16.94 -59.30 41.23 115.61

Competitive Comparison of JW Pharmaceutical's E10

For the Drug Manufacturers - Specialty & Generic subindustry, JW Pharmaceutical's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JW Pharmaceutical's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, JW Pharmaceutical's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where JW Pharmaceutical's Shiller PE Ratio falls into.



JW Pharmaceutical E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, JW Pharmaceutical's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=816/118.8477*118.8477
=816.000

Current CPI (Mar. 2024) = 118.8477.

JW Pharmaceutical Quarterly Data

per share eps CPI Adj_EPS
201406 -245.689 99.353 -293.897
201409 15.635 99.608 18.655
201412 3.499 99.098 4.196
201503 11.726 99.720 13.975
201506 -16.417 100.050 -19.501
201509 44.559 100.110 52.899
201512 35.606 100.220 42.224
201603 53.354 100.560 63.057
201606 -699.343 100.790 -824.638
201609 -203.565 101.460 -238.451
201612 329.085 101.560 385.102
201703 27.629 102.850 31.927
201706 -52.746 102.610 -61.093
201709 218.520 103.490 250.948
201712 -256.337 102.990 -295.806
201803 172.505 104.100 196.944
201806 324.515 104.130 370.382
201809 82.837 105.650 93.185
201812 -287.178 104.350 -327.077
201903 -196.861 104.490 -223.911
201906 63.588 104.880 72.057
201909 47.909 105.200 54.124
201912 -952.719 105.120 -1,077.135
202003 -97.795 105.540 -110.126
202006 -337.346 104.870 -382.309
202009 116.636 106.200 130.527
202012 -277.844 105.765 -312.211
202103 159.872 107.357 176.983
202106 -133.996 107.579 -148.032
202109 202.381 108.759 221.154
202112 -267.281 109.676 -289.631
202203 375.976 111.806 399.656
202206 33.314 114.083 34.705
202209 323.625 114.831 334.944
202212 509.233 115.200 525.356
202303 630.392 116.550 642.822
202306 531.373 117.140 539.120
202309 -727.451 119.111 -725.842
202312 1,014.780 118.848 1,014.780
202403 816.000 118.848 816.000

Add all the adjusted EPS together and divide 10 will get our e10.


JW Pharmaceutical  (XKRX:001060) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

JW Pharmaceutical's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=29600.00/115.61
=256.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of JW Pharmaceutical was 3486.85. The lowest was 248.25. And the median was 1671.12.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


JW Pharmaceutical E10 Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


JW Pharmaceutical (XKRX:001060) Business Description

Traded in Other Exchanges
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical (XKRX:001060) Headlines

No Headlines